1.
Figueroa-Valverde L, Rosas-Nexticapa M, Alvarez-Ramirez M, Mateu-Armad MV, Cauich-Carrillo R. Theoretical interaction of muscarinic receptor antagonist with vascular endothelial growth factor receptors (VEGF-R1, R2 and R3) as a therapeutic alternative to treat cancer. Braz. J. of Sci. [Internet]. 2025 Apr. 17 [cited 2025 Apr. 25];4(5):1-14. Available from: https://periodicos.cerradopub.com.br/bjs/article/view/734